224 related articles for article (PubMed ID: 32221555)
1. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
Taylor SM; Levitt B; Freedman B; Madanitsa M; Thwai KL; Kalilani-Phiri L; Khairallah C; Mwapasa V; Ter Kuile FO; Meshnick SR
J Infect Dis; 2020 Jul; 222(4):661-669. PubMed ID: 32221555
[TBL] [Abstract][Full Text] [Related]
2. The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women.
Gutman J; Kalilani L; Taylor S; Zhou Z; Wiegand RE; Thwai KL; Mwandama D; Khairallah C; Madanitsa M; Chaluluka E; Dzinjalamala F; Ali D; Mathanga DP; Skarbinski J; Shi YP; Meshnick S; ter Kuile FO
J Infect Dis; 2015 Jun; 211(12):1997-2005. PubMed ID: 25564249
[TBL] [Abstract][Full Text] [Related]
3. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
[TBL] [Abstract][Full Text] [Related]
4. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
[TBL] [Abstract][Full Text] [Related]
5. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
[TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine and parasite resistance: cross-sectional surveys from antenatal care visit and delivery in rural Ghana.
Mama A; Ahiabor C; Tornyigah B; Frempong NA; Kusi KA; Adu B; Courtin D; Houzé S; Deloron P; Ofori MF; Anang AK; Ariey F; Ndam NT
Malar J; 2022 Mar; 21(1):107. PubMed ID: 35346205
[TBL] [Abstract][Full Text] [Related]
7. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.
van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO
Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
[TBL] [Abstract][Full Text] [Related]
9. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
11. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
[TBL] [Abstract][Full Text] [Related]
13. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ; Thigpen MC; Parise ME; Newman RD
Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
[TBL] [Abstract][Full Text] [Related]
15. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
[TBL] [Abstract][Full Text] [Related]
16. Sustained clinical benefit of malaria chemoprevention with sulfadoxine-pyrimethamine (SP) in pregnant women in a region with high SP resistance markers.
Matambisso G; Brokhattingen N; Maculuve S; Cístero P; Mbeve H; Escoda A; Bambo G; Cuna B; Melembe C; Ndimande N; Tetteh KKA; Drakeley C; Gamain B; Chitnis C; Chauhan V; Quintó L; Macete E; Mayor A
J Infect; 2024 May; 88(5):106144. PubMed ID: 38574776
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Bwire GM; Mikomangwa WP; Kilonzi M
BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Tan KR; Katalenich BL; Mace KE; Nambozi M; Taylor SM; Meshnick SR; Wiegand RE; Chalwe V; Filler SJ; Kamuliwo M; Craig AS
Malar J; 2014 Jun; 13():227. PubMed ID: 24909578
[TBL] [Abstract][Full Text] [Related]
19. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]